| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 100 | $20.00 | $2k | | 06/08/2023 |
| 06/07/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 2.5k | $19.34 | $48.4k | | 06/06/2023 |
| 06/06/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 2.1k | $18.61 | $39.9k | | 06/06/2023 |
| 03/23/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 372 | $12.15 | $4.5k | | 03/21/2023 |
| 03/22/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 357 | $12.64 | $4.5k | | 03/21/2023 |
| 03/21/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 349 | $12.89 | $4.5k | | 03/21/2023 |
| 03/20/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 358 | $12.61 | $4.5k | | 03/17/2023 |
| 03/17/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 339 | $13.28 | $4.5k | | 03/17/2023 |
| 03/16/2023 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 336 | $13.43 | $4.5k | | 03/15/2023 |
| 03/15/2023 | Tarsus Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 4.8k | $0.00 | $0 | | 03/15/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 32.6k | $0.00 | $0 | | 03/08/2023 |
| 03/08/2023 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 48.1k | $15.00 | $721.7k | | 03/08/2023 |
| 11/15/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 6.9k | $17.72 | $121.5k | | 11/15/2022 |
| 08/24/2022 | Tarsus Pharmaceuticals, Inc. | | Exercise | Employee Stock Option (right to buy) | 4.4k | $10.99 | $48.5k | | 08/24/2022 |
| 08/24/2022 | Tarsus Pharmaceuticals, Inc. | | Exercise | Employee Stock Option (right to buy) | 772 | $0.45 | $347.4 | | 08/24/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 65.3k | $19.59 | $1.3M | | 03/09/2022 |
| 03/09/2022 | Tarsus Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 19.2k | $0.00 | $0 | | 03/09/2022 |
| 11/08/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 1.9k | $28.11 | $53.1k | | 11/08/2021 |
| 11/05/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 11 | $28.11 | $309.2 | | 11/04/2021 |
| 11/04/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 100 | $28.03 | $2.8k | | 11/04/2021 |
| 11/02/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 542 | $27.07 | $14.7k | | 11/02/2021 |
| 11/02/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 5.5k | $26.75 | $146k | | 11/02/2021 |
| 09/10/2021 | Tarsus Pharmaceuticals, Inc. | | Exercise | Employee Stock Option (right to buy) | 2.6k | $0.45 | $1.2k | | 09/10/2021 |
| 09/10/2021 | Tarsus Pharmaceuticals, Inc. | | Exercise | Employee Stock Option (right to buy) | 4.4k | $10.99 | $47.8k | | 09/10/2021 |
| 09/10/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 2.6k | $22.15 | $57.4k | | 09/10/2021 |
| 01/07/2021 | Tarsus Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 41k | $47.25 | $1.9M | | 01/07/2021 |